IHEEZO

Harrow Eye, LLC🇺🇸 United States

FDA Page

Effective Date: Mar 24, 2026
Approval ID: ea3b2d2c-8b33-d199-e053-2995a90a699c
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use IHEEZO safely and effectively. See full prescribing information for IHEEZO . IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3%, for topical ophthalmic use Initial U.S. Approval: 1955

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.